DYEE Capital is a private equity & venture capital firm.
Phone: +86 0592-2518818
Xiamen,
Fujian, China
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-10-21 | JingData | Series B | $15.02M | Lanpu Venture Capital, and ZJSTIC |
2020-09-27 | InventisBio | Series D | $147M | Advantech Capital, AIHC Capital, CMB International Capital, E Fund, Hillhouse Capital Management, Janchor Partners, Lilly Asia Ventures, Matrix Partners China, OrbiMed Advisors, Pudong Innotec, and Qiming Venture Partners |
2020-09-16 | KingYee | Series D | $63.62M | Guangrun Equity Investment, Longmen Capital, Meihe Zhongbang, Royal Sea Capital, and Tencent Holdings |
2020-08-19 | LP Pharmaceuticals | Series C | $72.34M | Fujian Investment and Development, Guigu Huoju Fund, Industrial Bank, Lapam Capital, Qian Dao Fund, Sequoia Capital China, Shenzhen Capital Group, and Zhongjin Chuanhua |
2019-12-28 | Elpiscience Biopharmaceuticals | Series B | $100M | CDH Investments, Hillhouse Capital Management, Hyfinity Investments, Juming Ventures, Lilly Asia Ventures, Oriza Holdings, Shenzhen GTJA Investment Group, Tencent Holdings, and WisdoMont |